These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3414260)

  • 21. L-dopa for the negative symptoms of schizophrenia.
    Berry T
    Am J Psychiatry; 1988 Sep; 145(9):1180-1. PubMed ID: 3414870
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serum thioridazine level and its antipsychotic effect measured by a general scale of psychopathology evaluation in patients with schizophrenia].
    Sidorowicz S; Chyczewski T; Janicka B; Sanecka B; Slepecka J; Wasik A
    Psychiatr Pol; 1986; 20(2):96-101. PubMed ID: 3786592
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of hostile, suspicious patients. Trifluoperazine versus haloperidol.
    O'Brien CP; DiGiacomo JN; Webb W
    Dis Nerv Syst; 1974 Feb; 35(2):75-8. PubMed ID: 17894044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should the Physician's Desk Reference contraindicate the use of chlorpromazine-fluoxetine combination? A case report.
    Adetunji B; Basil B; Mathews M; Osinowo T
    J Clin Psychopharmacol; 2006 Aug; 26(4):438. PubMed ID: 16855470
    [No Abstract]   [Full Text] [Related]  

  • 25. [Electroencephalographic profile and dynamics of individual changes in the EEG of paranoid schizophrenics during treatment with aminazine (clinico-electroencephalographic correlation)].
    Bochkarov VK; Nikiforov AI; Tsirkin SIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(8):1192-9. PubMed ID: 7315055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of vasopressin the treatment of the paranoid form of schizophrenia].
    Bakharev VD; Tikhomirov SM; Papsuevich OS; Chipens GI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(1):88-92. PubMed ID: 6142575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nursing care study: paranoid schizophrenia.
    Stevens P
    Nurs Mirror Midwives J; 1976 Apr; 142(16):49-51. PubMed ID: 1046217
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effectiveness of treating early-onset malignant schizophrenia with psychotropic drugs and their combinations].
    Sobolev ES; Zaĭtsev SG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(1):114-21. PubMed ID: 6111878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of systematic organization of the EEG in the diagnosis of psychopathologic states].
    Bochkarev VK; Nikiforov AI; Danilenko IuM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(12):1805-11. PubMed ID: 6141688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Structural-metabolic characteristics of erythrocyte membrane in patients with paranoid schizophrenia undergoing psychopharmacotherapy].
    Novitskiĭ VV; Riazantseva NV
    Eksp Klin Farmakol; 2002; 65(6):19-22. PubMed ID: 12596527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonazepam in the treatment of chronic schizophrenia.
    Raines JM; Greenspan D
    Am J Psychiatry; 1987 Nov; 144(11):1510. PubMed ID: 3674236
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of intensive hospital treatment on the duration of remissions among schizophrenics with a long history of the disease].
    Malakhov BB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):564-8. PubMed ID: 4267491
    [No Abstract]   [Full Text] [Related]  

  • 34. Investigation of serum cytokine levels and cytokine production in whole blood cultures of paranoid schizophrenic patients.
    Kamińska T; Wysocka A; Marmurowska-Michalowska H; Dubas-Slemp H; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):439-45. PubMed ID: 11814238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients.
    Singh B; Bera NK; Nayak CR; Chaudhuri TK
    Cytokine; 2009 Jul; 47(1):1-5. PubMed ID: 19502081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research design for analyzing drug-environment-behavior interactions.
    Liberman RP; Davis J; Moon W; Moore J
    J Nerv Ment Dis; 1973 Jun; 156(6):432-9. PubMed ID: 4711622
    [No Abstract]   [Full Text] [Related]  

  • 37. Paranoid schizophrenia. A serpent which licked my eyes..
    Hansford M
    Nurs Mirror; 1981 May; 152(19):30-3. PubMed ID: 6909921
    [No Abstract]   [Full Text] [Related]  

  • 38. Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients.
    Huang TL; Lee CT
    J Psychiatr Res; 2006 Oct; 40(7):664-8. PubMed ID: 16386272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chlorpromazine excretion. III. Fecal excretion of 14C-chlorpromzine in chronically dosed patients.
    Georgotas A; Serra MT; Green DE; Perel JM; Gershon S; Forrest IS
    Commun Psychopharmacol; 1979; 3(3):197-202. PubMed ID: 498751
    [No Abstract]   [Full Text] [Related]  

  • 40. [Changes in the serum thioridazine level after administration of pridinol].
    Sidorowicz S; Chyczewski T; Janicka B; Slepecka J; Sanecka B; Wasik A
    Psychiatr Pol; 1985; 19(5):423-4. PubMed ID: 3832136
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.